Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

Limited placebo-controlled data are available to assess the long-term fracture efficacy of bisphosphonates. In order to determine the effects of 5 years of risedronate treatment, we extended a 3-year, placebo-controlled vertebral fracture study in osteoporotic women for an additional 2 years; women...

Bibliografski detalji
Glavni autori:	Sorensen, O, Crawford, G, Mulder, H, Hosking, D, Gennari, C, Mellstrom, D, Pack, S, Wenderoth, D, Cooper, C, Reginster, J
Format:	Journal article
Jezik:	English
Izdano:	2003

Slični predmeti

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
od: Cooper, C, i dr.
Izdano: (2001)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
od: Raja Bobba, i dr.
Izdano: (2007-10-01)

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
od: Seeman, A, i dr.
Izdano: (2000)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
od: Ma. Florencia Peralta, i dr.
Izdano: (2021-05-01)

Histomorphometric Quantitative Evaluation of Long-Term Risedronate Use in a Knee Osteoarthritis Rabbit Model
od: Silvia Fernández-Martín, i dr.
Izdano: (2021-04-01)

No Effect of Long-Term Risedronate Use on Cartilage and Subchondral Bone in an Experimental Rabbit Model of Osteoarthritis
od: Silvia Fernández-Martín, i dr.
Izdano: (2020-11-01)

The mobile study long-term extension: Progressive improvements in efficacy with oral ibandronate (150mg) when administered monthly
od: Reginster, J, i dr.
Izdano: (2007)

Once-monthly risedronate for postmenopausal osteoporosis
od: Kristina Casadei, i dr.
Izdano: (2009-02-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
od: Paula Rackoff
Izdano: (2009-05-01)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
od: Stefano Palomba, i dr.
Izdano: (2010-06-01)

Risedronate-loaded aerogel scaffolds for bone regeneration
od: Nahla El-Wakil, i dr.
Izdano: (2023-12-01)

Effect of risedronate on bone loss at discontinuation of denosumab
od: Michel Laroche, i dr.
Izdano: (2020-12-01)

Risedronate inhibits human osteosarcoma cell invasion
od: Jung Sung, i dr.
Izdano: (2009-07-01)

Preparation of Risedronate Nanoparticles by Solvent Evaporation Technique
od: Eliska Vaculikova, i dr.
Izdano: (2014-11-01)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
od: Diane Kleinermans, i dr.
Izdano: (2022-06-01)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
od: Watts, N, i dr.
Izdano: (2004)

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
od: Seeman, E, i dr.
Izdano: (2010)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
od: Kashemirov, B, i dr.
Izdano: (2008)

The Potential of Bisphosphonate Risedronate Hydrogel in Preventing Relapse Movement
od: Utari, Tita Ratya, i dr.
Izdano: (2022)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
od: Abdurrahman Yeter, i dr.
Izdano: (2014-12-01)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
od: Roelofs, A, i dr.
Izdano: (2005)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
od: Marma, MS, i dr.
Izdano: (2007)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
od: María J Moro-Álvarez, i dr.
Izdano: (2008-06-01)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
od: Coxon, F, i dr.
Izdano: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
od: Coxon, F, i dr.
Izdano: (2008)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
od: Duncan, E, i dr.
Izdano: (2005)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
od: Yohei Asada, i dr.
Izdano: (2019-01-01)

The Effects of Risedronate Treatment on the Pain and the Quality of Life - Original Investigation
od: Evrim Karadağ Saygı, i dr.
Izdano: (2009-08-01)

Development of Risedronate-Loaded Nano Capsules for Calvaria Healing in Rabbit
od: Hesam Aldin Hoseinzadeh, i dr.
Izdano: (2019-04-01)

A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis
od: Satoshi Soen, i dr.
Izdano: (2020-12-01)

Disturbance of osteonal bone remodeling and high tensile stresses on the lateral cortex in atypical femoral fracture after long-term treatment with Risedronate and Alfacalcidol for osteoporosis
od: Fumitaka Hirano, i dr.
Izdano: (2021-06-01)

Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
od: Bala, Y, i dr.
Izdano: (2014)

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial
od: Shaun G. Goodman, i dr.
Izdano: (2023-09-01)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
od: Jean-Yves Reginster, i dr.
Izdano: (2014-02-01)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
od: Tahir Masud, i dr.
Izdano: (2009-11-01)

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits
od: Shabnam Aghayan, i dr.
Izdano: (2021-03-01)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
od: Vincenzo Monda, i dr.
Izdano: (2017-09-01)

Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis
od: Brounais-Le Royer, B, i dr.
Izdano: (2012)

Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats.
od: Tingjun Ye, i dr.
Izdano: (2017-01-01)

Effectiveness of Short-Term Use Denosumab and Risedronate Using β-Crosslaps and Histopathology as a Parameter in Osteoporotic Rat Model
od: Afrisya Bimo Siwendro, i dr.
Izdano: (2024-09-01)